CDER’s 14 Approvals In The First Half Of 2016
Interactive table shows the new molecular entity and novel therapeutic biologics approved by FDA in the first half of 2016.
Interactive table shows the new molecular entity and novel therapeutic biologics approved by FDA in the first half of 2016.